World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $102.73bn | 28.61 | n/a |
REGNRegeneron Pharmaceuticals | $97.32bn | 24.26 | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $42.63bn | 30.35 | n/a |
LONNLonza AG | CH₣38.06bn | 36.65 | 0.76% |
MRNAModerna | $41.34bn | n/a | n/a |
068270Celltrion | KR₩38tn | 46.88 | 0.28% |
ICLRIcon | $25.49bn | 34.09 | n/a |
ARGXargenx SE | €20.76bn | n/a | n/a |
BNTXBioNTech SE | $20.73bn | 20.56 | n/a |
GMABGenmab A/S | DKK127.78bn | 29.6 | n/a |
ALNYAlnylam Pharmaceuticals | $18.05bn | n/a | n/a |
NBIXNeurocrine Biosciences | $13.68bn | 38.38 | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
MEDPMedpace Holdings | $12.27bn | 40.34 | n/a |
SRPTSarepta Therapeutics | $12.17bn | n/a | n/a |
CRLCharles River Laboratories International | $11.80bn | 28.92 | n/a |
UTHRUnited Therapeutics | $11.00bn | 11.77 | n/a |
EXASExact Sciences | $10.82bn | n/a | n/a |
TECHBIO-TECHNE | $10.07bn | 44.5 | 0.5% |